What are Testosterone Disorders?
There are several diseases that can affect testosterone, a hormone that is produced by the testes in men and the ovaries in women. Testosterone plays a crucial role in many bodily functions, including the development of male sex organs, muscle mass, and body hair.
Some of the diseases that can affect testosterone levels include:
- Hypogonadism: This is a condition in which the body does not produce enough testosterone. It can be caused by a range of factors, including damage to the testes or problems with the pituitary gland, which produces hormones that regulate the testes.
- Klinefelter syndrome: This is a genetic disorder that affects males and is caused by an extra X chromosome. It can lead to low testosterone levels and other problems.
- Testicular cancer: This is a type of cancer that affects the testes and can lead to a decrease in testosterone production.
- Pituitary tumors: Tumors that affect the pituitary gland can interfere with the production of hormones that regulate the testes, leading to low testosterone levels.
- Aging: Testosterone levels naturally decrease with age, and older men may have lower levels of the hormone than younger men.
Overall, there are several diseases that can affect testosterone levels, and it is important for individuals with these conditions to receive appropriate medical care and support to manage their symptoms and maintain good health.
Diabetes & Thyroid Metabolic Clinic focuses in testosterone care and management in El Paso, Texas, and we are committed to providing personalized care and culture-sensitive treatment to all of our patients.
Testosterone Care & Management
Care begins with an evaluation of symptoms and possible causes. In men, hypogonadism requires compatible symptoms or signs and consistently low testosterone confirmed with at least two early-morning blood tests. A single result or fatigue alone does not establish the diagnosis.
Treatment may include addressing underlying conditions, reviewing medicines, lifestyle support, or testosterone therapy when appropriate. Testosterone treatment can suppress sperm production and is generally avoided when planning fertility. Discuss your reproductive goals before treatment.
Potential benefits, risks, formulation, and monitoring should be individualized. Follow-up may include symptom assessment, testosterone and blood-count testing, blood pressure, and prostate-risk evaluation when appropriate.
Learn more: Endocrine Society: hypogonadism in men.
Hypogonadism
Hypogonadism is a condition in which the body does not produce enough testosterone, a hormone that plays a crucial role in male sexual development and fertility. Testosterone is also important for maintaining muscle mass, bone density, and other physical and emotional characteristics. There are two main types of hypogonadism: primary and secondary. Primary hypogonadism occurs when the testicles are not functioning properly, while secondary hypogonadism occurs when there is a problem with the pituitary gland or hypothalamus, which regulate testosterone production.
Symptoms of low testosterone (hypogonadism) may include;
- Changes in mood
- Decreased Energy
- Weight Gain
- Decreased sex drive
- Difficulty getting or maintaining an erection
- Decreased muscle mass
- Decreased bone density
- Hot flashes
- Breast swelling
Hypogonadism can have a significant impact on overall health and well-being, so it is important to get diagnosed and treated if you have any symptoms or risk factors for the condition.
Aging and Testosterone
Testosterone levels may decline with age, but the pattern varies. Obesity, sleep problems, other illnesses, and some medicines can also affect levels.
Age alone is not a reason to start testosterone therapy. If symptoms are concerning, an evaluation can help identify their cause and determine whether further testing or treatment is appropriate. Nutrition, physical activity, sleep, and treatment of underlying conditions remain part of individualized care.
Learn more: Endocrine Society 2026 statement on testosterone treatment.
